BioCentury
ARTICLE | Company News

De Novo, Organon small molecule deal

March 9, 2001 8:00 AM UTC

Organon (Oss, the Netherlands) received access to De Novo's computer algorithms to develop new small molecule leads from structural genomics and medicinal chemistry information. De Novo ( Cambridge, U...